Investigations of the ‘active’ edge of plaque psoriasis: vascular proliferation precedes changes in epidermal keratin

We have investigated markers of epidermal proliferation and differentiation in terms of keratin expression, the morphology of the cutaneous vasculature, and numbers of cutaneous mast cells, in patients with chronic plaque psoriasis. Using the phenomenon of the ‘active edge’, we have studied these features in the psoriatic plaque itself, and in the clinically normal active and inactive edges of the same plaque. Our results confirm the anticipated changes in keratin profiles, mast cell numbers and psoriatic morphology of the vasculature within the plaque itself. They further indicate that the vascular changes precede the epidermal and mast cell features at the active edge, and that the inactive edge is inactive for all of these variables. Mediators responsible for the vascular proliferation and elongation must be present in increased amounts at the active edge when compared with the inactive, and include locally produced and circulating factors.

[1]  I. Hunter,et al.  Protein modifications during the keratinization of normal and psoriatic human epidermis. , 1978, Biochimica et biophysica acta.

[2]  James T. Elder,et al.  Overexpression of transforming growth factor alpha in psoriatic epidermis. , 1989, Science.

[3]  J. B. Ross THE PSORIATIC CAPILLARY , 1964 .

[4]  W. Cunliffe,et al.  Modification of human prekeratin during epidermal differentiation. , 1981, The Biochemical journal.

[5]  B. Haynes,et al.  Monoclonal antibody 4F2 reactive with basal layer keratinocytes: studies in the normal and a hyperproliferative state. , 1984, The Journal of investigative dermatology.

[6]  J. Bos,et al.  The pathomechanisms of psoriasis; the skin immune system and cyclosporin , 1988, The British journal of dermatology.

[7]  L. Nanney,et al.  Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis. , 1986, The Journal of investigative dermatology.

[8]  F. Kerdel,et al.  The mast cell in health and disease. , 1990, Journal of the American Academy of Dermatology.

[9]  W. Cunliffe,et al.  Comparison of prekeratin and keratin polypeptides in normal and psoriatic human epidermis. , 1983, Biochimica et biophysica acta.

[10]  Benjamin Geiger,et al.  The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells , 1982, Cell.

[11]  P. V. D. van de Kerkhof,et al.  Markers for proliferation and keratinization in the margin of the active psoriatic lesion. , 1990, The British journal of dermatology.

[12]  D. Macdonald,et al.  Human cutaneous mast cells–a study of fixative and staining reactions in normal skin , 1989, The British journal of dermatology.

[13]  B. Bernard,et al.  Spreading of psoriatic plaques: alteration of epidermal differentiation precedes capillary leakiness and anomalies in vascular morphology. , 1990, The Journal of investigative dermatology.

[14]  J. B. Ross,et al.  THE PSORIATIC CAPILLARY: ITS NATURE AND VALUE IN THE IDENTIFICATION OF THE UNAFFECTED PSORIATIC. , 1964, The British journal of dermatology.

[15]  W. Cunliffe,et al.  Active and inactive edges of psoriatic plaques: identification by tracing and investigation by laser--Doppler flowmetry and immunocytochemical techniques. , 1989, The Journal of investigative dermatology.

[16]  B. Nickoloff,et al.  Role of interferon-gamma in cutaneous trafficking of lymphocytes with emphasis on molecular and cellular adhesion events. , 1988, Archives of dermatology.

[17]  C. Hodgson,et al.  THE UPTAKE OF 3H‐THYMIDINE BY EPIDERMAL CELLS IN NORMAL AND PSORIATIC SUBJECTS. , 1966, The British journal of dermatology.

[18]  J. Voorhees,et al.  Cyclic nucleotide levels in psoriatic and normal keratomed epidermis. , 1979, The Journal of investigative dermatology.

[19]  J. Voorhees,et al.  Decreased protein kinase C activity in psoriatic versus normal epidermis. , 1987, The Journal of investigative dermatology.

[20]  E. Jong,et al.  Markers for proliferation and keratinization in the margin of the active psoriatic lesion , 1990 .

[21]  G. Krueger,et al.  Involved and uninvolved skin from psoriatic subjects: are they equally diseased? Assessment by skin transplanted to congenitally athymic (nude) mice. , 1981, Journal of Clinical Investigation.

[22]  D. Ruiter,et al.  Monoclonal antibody-defined human endothelial antigens as vascular markers. , 1989, The Journal of investigative dermatology.

[23]  I. Braverman,et al.  Role of the microcirculation in the treatment and pathogenesis of psoriasis. , 1982, The Journal of investigative dermatology.